Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Secondary Prevention of Small Subcortical Strokes (SPS3) Trial
NCT00059306Phase 3Completed
- Sponsor
- University of British Columbia
- Start
- Feb 2003
- Primary completion
- Apr 2012
- Modality
- Small Molecules
- Countries
- 7
01
Overview
A Phase 3 trial of clopidogrel in cerebrovascular accident (CVA), sponsored by University of British Columbia. Started Feb 2003; status: completed.
02
Drugs
clopidogrel
03
Conditions
cerebrovascular accident (CVA)
Beyond the preview
Go deeper on NCT00059306.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00059306.